Table 2. Clinicopathological findings of ovarian cancers we examined.
| Histological type of tumor | |||||
|---|---|---|---|---|---|
| Total (%) | SC (%) | MC (%) | EC (%) | CCC (%) | |
| Total | 162 | 62 (38.3) | 17 (10.5) | 40 (24.7) | 43 (26.5) |
| Median age (Range) |
56.5 (29–80) |
58.5 (31–79) |
65 (29–80) |
57.5 (31–80) |
53 (30–78) |
| FIGO stage | |||||
| I | 69 (42.6) | 8 (12.9) | 14 (82.4) | 22 (55.0) | 25 (58.2) |
| II | 18 (11.1) | 9 (14.5) | 0 (0) | 5 (12.5) | 4 (9.3) |
| III | 56 (34.6) | 37 (59.7) | 3 (17.6) | 7 (17.5) | 9 (20.9) |
| IV | 19 (11.7) | 8 (12.9) | 0 (0) | 6 (15.0) | 5 (11.6) |
| Adjuvant chemotherapy | 139 (85.3) | 59 (95.1) | 7 (41.2) | 34 (85.0) | 39 (90.7) |
| Recurrence | 67 (41.4) | 33 (53.2) | 3 (17.6) | 8 (20.0) | 23 (53.5) |
| Median recurrence (range)(day) |
400 (50–1329) |
517 (106–1329) |
231 (306–722) |
275 (106–819) |
381 (50–1260) |
Abbreviations: SC; Serous carcinoma, MC; Mucinous carcinoma, EC; Endometrioid carcinoma, CCC; Clear cell carcinoma.